ResearcherPeking UniversityNo recent work listed
Long Di
Matched on ORCID iD 0000-0001-7986-0393; OpenAlex author ID A5111048064. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2022: 2 papers · 2023: 2 papers
Papers 4
- The benefits of neoadjuvant therapy for patients with resectable pancreatic cancer: an updated systematic review and meta-analysis. Co-author DOI 10.1007/s10238-023-01112-2↗
- Single-cell RNA-seq reveals characteristics in tumor microenvironment of PDAC with MSI-H following neoadjuvant chemotherapy with anti-PD-1 therapy. Co-author DOI 10.1016/j.canlet.2023.216421↗
- Development and validation of prognostic and diagnostic model for pancreatic ductal adenocarcinoma based on scRNA-seq and bulk-seq datasets. Co-author DOI 10.1093/hmg/ddab343↗
- Emerging Role of Exosomal-Derived Long Noncoding RNAs in Human PDAC. Co-author DOI 10.1159/000520947↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaodong Tian · 3 shared papers, 2022–2023 · strength 0.55
- Paper Single-cell RNA-seq reveals characteristics in tumor microenvironment of PDAC with MSI-H following neoadjuvant chemothe… DOI 10.1016/j.canlet.2023.216421↗
- Paper The benefits of neoadjuvant therapy for patients with resectable pancreatic cancer: an updated systematic review and me… DOI 10.1007/s10238-023-01112-2↗
- Paper Development and validation of prognostic and diagnostic model for pancreatic ductal adenocarcinoma based on scRNA-seq a… DOI 10.1093/hmg/ddab343↗
- Yinmo Yang · 2 shared papers, 2022 · strength 0.43
- Yongsu Ma · 2 shared papers, 2023 · strength 0.38
- Paper Single-cell RNA-seq reveals characteristics in tumor microenvironment of PDAC with MSI-H following neoadjuvant chemothe… DOI 10.1016/j.canlet.2023.216421↗
- Paper The benefits of neoadjuvant therapy for patients with resectable pancreatic cancer: an updated systematic review and me… DOI 10.1007/s10238-023-01112-2↗
- Yinmo Yang · 2 shared papers, 2023 · strength 0.38
- Paper Single-cell RNA-seq reveals characteristics in tumor microenvironment of PDAC with MSI-H following neoadjuvant chemothe… DOI 10.1016/j.canlet.2023.216421↗
- Paper The benefits of neoadjuvant therapy for patients with resectable pancreatic cancer: an updated systematic review and me… DOI 10.1007/s10238-023-01112-2↗
- Kai Chen · 2 shared papers, 2022–2023 · strength 0.37
- Paper Single-cell RNA-seq reveals characteristics in tumor microenvironment of PDAC with MSI-H following neoadjuvant chemothe… DOI 10.1016/j.canlet.2023.216421↗
- Paper Development and validation of prognostic and diagnostic model for pancreatic ductal adenocarcinoma based on scRNA-seq a… DOI 10.1093/hmg/ddab343↗
- Lei Zheng · 1 shared paper, 2023 · strength 0.19
- Bohan Yang · 1 shared paper, 2023 · strength 0.18
- Yingjin Wang · 1 shared paper, 2023 · strength 0.18
- Weikang Liu · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.